SG Americas Securities’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,085
| Closed | -$298K | – | 3706 |
|
|
2022
Q2 | $298K | Buy |
9,085
+5,047
| +125% | +$160K | ﹤0.01% | 2385 |
|
|
2022
Q1 | $106K | Buy |
+4,038
| New | +$98.6K | ﹤0.01% | 2754 |
|
|
2021
Q4 | – | Sell |
-4,992
| Closed | -$125K | – | 3966 |
|
|
2021
Q3 | $125K | Buy |
+4,992
| New | +$127K | ﹤0.01% | 3558 |
|
|
2021
Q2 | – | Sell |
-4,242
| Closed | -$109K | – | 3380 |
|
|
2021
Q1 | $109K | Sell |
4,242
-2,913
| -41% | -$74.7K | ﹤0.01% | 3045 |
|
|
2020
Q4 | $143K | Sell |
7,155
-19,002
| -73% | -$372K | ﹤0.01% | 2847 |
|
|
2020
Q3 | $448K | Buy |
+26,157
| New | +$494K | ﹤0.01% | 1700 |
|
|
2020
Q2 | – | Sell |
-7,653
| Closed | -$177K | – | 3921 |
|
|
2020
Q1 | $177K | Buy |
7,653
+2,869
| +60% | +$83.4K | ﹤0.01% | 2594 |
|
|
2019
Q4 | $158K | Sell |
4,784
-54,894
| -92% | -$1.76M | ﹤0.01% | 2654 |
|
|
2019
Q3 | $1.9M | Buy |
59,678
+55,596
| +1,362% | +$1.62M | 0.02% | 995 |
|
|
2019
Q2 | $105K | Sell |
4,082
-9,802
| -71% | -$250K | ﹤0.01% | 2787 |
|
|
2019
Q1 | $352K | Buy |
13,884
+9,690
| +231% | +$289K | ﹤0.01% | 2136 |
|
|
2018
Q4 | $143K | Sell |
4,194
-700
| -14% | -$22.8K | ﹤0.01% | 2543 |
|
|
2018
Q3 | $174K | Sell |
4,894
-7,436
| -60% | -$263K | ﹤0.01% | 2631 |
|
|
2018
Q2 | $425K | Buy |
12,330
+8,631
| +233% | +$303K | ﹤0.01% | 2125 |
|
|
2018
Q1 | $124K | Buy |
+3,699
| New | +$117K | ﹤0.01% | 2776 |
|
|
2017
Q4 | – | Sell |
-3,685
| Closed | -$138K | – | 3771 |
|
|
2017
Q3 | $138K | Buy |
+3,685
| New | +$130K | ﹤0.01% | 2932 |
|
|
2017
Q2 | – | Sell |
-13,592
| Closed | -$533K | – | 3627 |
|
|
2017
Q1 | $533K | Buy |
13,592
+8,863
| +187% | +$333K | ﹤0.01% | 1812 |
|
|
2016
Q4 | $165K | Sell |
4,729
-3,639
| -43% | -$143K | ﹤0.01% | 2503 |
|
|
2016
Q3 | $329K | Sell |
8,368
-2,399
| -22% | -$95.7K | ﹤0.01% | 2092 |
|
|
2016
Q2 | $407K | Buy |
10,767
+6,305
| +141% | +$211K | ﹤0.01% | 1819 |
|
|
2016
Q1 | $171K | Buy |
+4,462
| New | +$166K | ﹤0.01% | 2292 |
|
|
2015
Q4 | – | Sell |
-3,311
| Closed | -$131K | – | 3062 |
|
|
2015
Q3 | $131K | Sell |
3,311
-1,191
| -26% | -$50.6K | ﹤0.01% | 1700 |
|
|
2015
Q2 | $192K | Buy |
+4,502
| New | +$179K | ﹤0.01% | 2005 |
|
|
2015
Q1 | – | Sell |
-7,030
| Closed | -$253K | – | 3182 |
|
|
2014
Q4 | $253K | Buy |
+7,030
| New | +$236K | ﹤0.01% | 2229 |
|
Other funds holding NTUS
SG Americas Securities's NTUS Position: Q3 2022 in Review
SG Americas Securities sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 9,085 shares — an estimated $298K sold.
SG Americas Securities first reported a position in NTUS in Q4 2014 and held it in 24 quarters. The position peaked at $1.9M in Q3 2019. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- SG Americas Securities reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- SG Americas Securities sold 9,085 Natus Medical Inc shares in Q3 2022, an estimated $298K.
- SG Americas Securities first reported a position in Natus Medical Inc in Q4 2014 and held it in 24 quarters.
- SG Americas Securities's Natus Medical Inc position peaked at $1.9M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on SG Americas Securities's 13F filing for Q3 2022, filed 31 Oct 2022.